conference

adcom

Ardelyx Inc

approval

$ARDX what fucking morons are selling it’s approved there are some real dumb fucks involved in this stock good let them get the fuck out. Pussys

$ARDX if we have no approval  you know they are corrupt. .

$ARDX with a 98% chance of fda approval within a few weeks, what is this crap?

Denial of approval of such product  will need a strong justification or presence of significant risk (which is not applicable for Tenapanor as elaborated in the above detailed  
analysis).

but not expecting a ton of juice upon approval 🤞

$ARDX with all due respect, this price action today is embarrassing…nasdaq up 6% we can’t even break $1.30 embarrassing for real… I won’t even be surprised if we get approval next week and we stay stagnant for a bit.

The issue raised was probably one of the only negatives for approval:  The fact that we are using &#39;surrogate&#39; endpoints rather than the correlated clinical outcome.

Tena is already approved for IBS with a solid safety profile, and phosphorus management is a real issue in the CKD community with only binders being available.

insider

One red flag in this company, despite one director buying 1m worth recently, is the low insider ownership.

$ARDX less than one dollar soon insiders doing, given how corrupt the board and CEO are .

$ARDX company doesn’t say anything, insiders don’t buy, stock trades like total crap.

Kind of thing you expect to happen to a stock if the CEO is complicit in a INSIDER Trading SCHEME. .

patient

Those laxatives your taking are not working, you need the full Fleets treatment, a complete system flush.

I still remember listening to the meeting and getting mad at Alikhani, the so called patient&#39;s advocate.

The subsequent increase in intraluminal pressure leads to decreased intestinal blood flow, and in the case of our patient, intestinal ischemia.

They got something that improve the quality of life for dialysis patients and you guys called the trash company.

$ARDX&quot; I am a board-certified nephrologist for 30 years and was very disappointed to say the least by the denial of application of Tenapanor for hyperphosphatemia in patients with CKD.

However, the enrichment strategy did not appear to reliably identify patients who would have a larger treatment response to tenapanor.

As you think about your decision, I’d like to ask you to remember me and the other patients out there like me who are looking for solutions to help them.

Company sitting on the best fundamentals ever to date and we get treated to these stupid 1 liner worthless post.

However when patients get discharged compliance will still remain an issue because nurses and doctors aren’t there watching over them and making sure they take their meds.

trading

Obvious, as hell looking at tape today this trading was far from organic.

↳ Why are you paying to be in a Trading Room?

$ARDX 
With these absurd disconnected 80-100million-share volumes, trading price purely a construction of Dark pool, HFT, MM share-swapping, etc.

In the scientific community as well as in trading feeling get fucked.

reason

what a BS TREE SHAKE by MM&#39;s today was zero reason to let this drop like they did. .

I see no reason to hold or add at this point.

There would be no other reason for the timing.

$ARDX Ok, the only reason to deny our drug is negligible efficacy.

but that the FDA had denied access to for reasons no one understood.

Must be the reason this can’t get past 1.5

There is no reason for it to fall today like this!

He is one of the reasons that the SP stays down.

$ARDX very good fda news on this conference call

$ARDX Idk man, it feels like a positive atmosphere at the conference, they chill and cool.

$ARDX Everything Ardelyx has been doing recently this year all the conferences shows etc demonstrates a bullish sentiment.

$ARDX I am thrilled that the chairwoman of our Adcom gave monotherapy a thumbs up.

So glad that I bought before ADCOM meeting.

$ARDX cytk failed Adcom yesterday, and went up! 😆

For the ADCOM had cast their votes, and they were overwhelmingly positive.

bullish because everything that has passed adcom this year has passed FDA!

ADCom approval big + 
2. Insider spent 1M on buying shares at 1.75$ 
3.

$ARDX  We saw 1 leg, and nice consolidation today, post adcom.

With a positive adcom that occurred you are golden adding anything under $3.

All in all with the Adcom, insider buy and how Ibsrela is doing looking good here.

I am confident the AdCom will vote in favor of approval.

news

$ARDX Looking good, would be nice to finish the day in the 4&#39;s 
 
Still waiting on positive news from the company.

$ARDX just keeps doing things well, and good news should arrive soon!

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$ARDX LOL, soon Xenopah News  😁 
Stay in, or buy

$ARDX good news coming man let’s goooooo

$AKBA within 3  to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

application

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

Better than money in the bank with soon resubmission and approval 2-6 months later!

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

bull

🎉

Have a great evening bulls and longs. 🍻🍻🍻

Hold strong bulls we’re not going anywhere 😤

$ARDX I’ll see you bulls in the 3.90s today 😤

$ARDX wow and just like that there’s no more bulls 🤣🤣🤣

A close above 4 will be huge for the bulls

Cheers and see you all tomorrow bulls and longs. 🍻

$ARDX  Looks like a bull flag on the daily morning here.

$ARDX $APRN $BLBX Have a great night, Bulls and Bull-ettes! !

Ocugen Inc

rate

Strange responses for a company with such high turnover rate and ranked #1 place to work at?

next big news: heart attack rates highest ever in march 2023, courtesy of crap admin

OCGN IS on a cash burn rate countdown to zero and no longer has ANY CREDIBILITY with the investment industry.

Ocgn is on cash burn rate countdown to zero. Duh.

Currently 3 cents above 52 week low, on cash burn rate countdown to zero or more Dilution, the dumbest meme stock failure in the history of meme stocks, attracts paid pumpers to tell you that the sky is the limit !!!

The rate of borrowing is f&#39;king ridiculous.

Literally the turnover rate is higher then fast food industry.

interest

Fake news or hype: Scammers may use fake news or hype to generate interest in their stock.

They’ll NEVER make it as traders bc they have no interest in learning and developing their craft.

$OCGN  and still you are here..with no interest whatsover. pathetic

$OCGN Short interest declining steadily since April..

but think they would be perfect for the fda- pretending to have our best interest at heart but just corrupt to the core.

They have no vested interest here ….APPARENTLY!!!!

$OCGN Or muppets with apparently no interest !!!

demoncrats

$OCGN This market is garbage.. Ty Biden voters..

Powell and that other worthless moron sleepy Joe are destroying this company one day at a time.

$OCGN Fck Biden that scum 🪣 bucket is the worst president in history!

$OCGN $ZOM Joe Biden literally the worst think to happen to America since my birth, holy shit.

$OCGN fuck Shankar, fuck Ocugen, fuck FDA, fuck Biden that is all.

Thanks Joe Biden you absolute fucking waste of a president.

Because the Democrats do not care about the middle

Biden&#39;s obviously corrupt and complicit media covering it up.

product

Nothing about her putting her seal of approval on any OCGN product.

Here you see a paid basher trying to spread misinformation, originating from the vaccine manufacturers themselves, to try to discredit the product our company is developing.

$OCGN OCGN pipeline consists of unwanted, mediocre at best, not financially viable products.

But there is not enough product that&#39;s its a big old NOTHING BURGER terms of sales.

There is no manufacturing or product lot release without a Quality a team.

Nothing says a tech transfer needs a fda approved product that’s beyond idiotic.

Big pharma is evil - our eye, knee, gene modifier products are a threat their evil as well.

Again they failed to bring this product to market and are so late its laughable.

fear

There only joy is fear and literally getting enjoyment of bothering others -like mosquitos - it’s really sad and a mental issue

Fear, and manipulation thrown to neophyte readers.

$OCGN  This poster is bashing and engaged in hate mongering without providing any substantive analysis or documentary evidence to support hisr allegations.

Great start to JP Morgan healthcare conference 1/9/23-1/12/23.

$OCGN 
Launch of UK Doctors Conference a Great Success

https://worldcouncilforhealth.org/news/statements/uk-doctors-conference-success/

pre positivenews from conferences and no holiday.

$PBLA $PLX $GMDA $OCGN check out $CDTX pdufa March 22nd (ADCOM favor 14-1) , offering done , milestone payment ahead 
Many positive news 💎💎💎

$OCGN  nice liking the price today okiee https://www.reddit.com/r/shortsqueeze2023/comments/11t3p7v/what_to_expect_for_ocgn_must_read/?utm_source=share&amp;utm_medium=ios_app&amp;utm_name=iossmf

$OCGN OCGN  &amp; PLSH  on cannabinoid research and now the stocks  almost the same share price what a golden opportunity go Ocu400

$OCGN LA is an easy flight for me &amp; my job is remote.

Please may I have some more !!!!!! https://giphy.com/gifs/D3OdaKTGlpTBC?utm_source=media-link&amp;utm_medium=landing&amp;utm_campaign=Media%20Links&amp;utm_term=

$ADXN as a successful former business owner and successful investor, I think that after this company tripling and now expecting epilepsy news, they are 1000% bullish they are going to going to the next phase with Johnson &amp; Johnson.

😎🍺😎
ABSOLUTELY BULLISH™️ https://twitter.com/healthbyjames/status/1620023652069810176?s=12&amp;t=s4vxK6BaKwF7YpJGclvpAg

bullish

$OCGN as scouser would say ABSOLUTELY BULLISH 😎

$OCGN bullish, what to expect moving forward for ocgn https://www.reddit.com/r/shortsqueeze2023/comments/11ntw73/what_to_expect_for_ocgn_going_into_marchapril_of/

sign

$OCGN I like the silence, usually a good sign

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) :⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

Steady and strong, it charges ahead, 
A sign of growth and prosperity, no need to be misled.

Akebia Therapeutics Inc.

board

Lack of integrity he said to people here TBLT will go to 1.22 prereverse split.. 183 pathetic scam, he said from his heart please just kick his ass out of your boards..

$AKBA Going to be disappointment on board today.

This board is a dumpster fire filled with a bunch of amateurs who have no clue how biotech regulatory processes actually work.

So much BS on the board I don’t even wanna go through it to find the posts of substance.

Idiots on this board only wanting to make money and don&#39;t care about the safety issues.

Whole army of paid clowns appearing, board is poisoned.

$AKBA this board sucks today.. so much garbage and random people

$AKBA The current optimism of this board suddenly has me uneasy!!

When the board starts acting like this, it’s never a good sign.

but already looking like another big mistake to add to my list of big mistakes..!

$AKBA Definitely doesn’t look good, big volume!

$AKBA Company is one big failure after another.

$AKBA fukk i hate this feeling of fomo, so sad i didnt load up big sub 0.3, i would love to stack up now

If there really are big dark pool buys, Something is definitely up.

$AKBA  not even trying to expect something big.

cancer

Hazard ratios for Dapro quite bad fri malignancy, skin premalignant disorders, hypoplastic anemias, breast malignancy tumors, colorectal, prostrate, and especially renal neoplasms.

In contrast, in the NDD population, daprodustat appears to have several other important risks in addition to the risks of heart failure and bleeding gastric erosions.

Their hazard ratios are much higher than 1 meaning that very much Dapro has a propensity to cancer compared to esas.

level

$AKBA I see who apparently accept and like free speech being subjected to this level of personal attacks.

You’ll know because all the scratches will be hub cap level!

$AKBA at adcom do u know if there was any word of why gsk limited their Hb levels to essentially 10.5 not even 11 whereas other drugs vad and Roxa went up to 12 for Hb thusly gsk DD artificially looks a lot safer than it really is.

trap

Was it a bear trap by JB, or is he playing games again?

$AKBA pre-market is a Bull trap 
 
In my opinion and no advice.

$AKBA Nice, I didn&#39;t know they were present at the annual JP Morgan medi conference! Expect some upgrades I think ;)

Nothing bigger in visibly than an 8 hour adcom so much more visibility than even the ASN conference.

$AKBA 
✅Mini Adcom granted
✅Friday RS explained 
✅More senior official in charge
❌Extra wait required 

I can wait; I’m happy with PR today.

Big bounce on ADCOM PR, and then another on positive ADCOM.

$AKBA love the climb.. break of .35 will be big and clear the way for .45 $SPY $QQQ  $XBI  eu approval partnership ards fda resubmit adcom all could be in the next few months

Imho akba vad is also safest HIF on market n gsk recently got DD adcom nod yes.

GSK ADCOM success increased Vada’s attractiveness to suitors.

We have a positive entryway for PIFs now thanks to gsk adcom today.

takes a LITTLE BIT more time very very well worth it …” Was Butler telegraphing how much time is left for the release of news that will create a parabolic move?

$AKBA when we get good news im getting  my lady pregnant!!!!. .again!!

I’m assuming this one will be very positive with EU partnership news.

seem really cheap with all the potential news coming. .

That would fry any naked short and short and would shoot up stock price to the floor it should be at, with this positive chmp and soon to be formal ema approval news, that is $5 a share, minimum.

And some are saying oh its just an opinion, this is actually fantastic news for us and will open the door to other countries for approval and HOPEFULLY the US fda will approve it.

share

Shares gained +283.6% since the last report https://tinyurl.com/y6823mqe

There goes all the compliance problems in one straight shot and those shares would be worth a ton more.

I have about 234k shares and im already up 120%

$AKBA - great news, 

Ended up getting 60,500 shares for just under $40k in my lotto account.

$AKBA Loved seeing my shares in the green for a few minutes.

$AKBA What a great time to add a few more shares.

Im up around 190% and i stil havnt sold a single share

$AKBA great day, actually great week, will not sell or trim a single share until $3+ 
 
I have great confidence in her for another 300%+ 
 
.26 --&gt; 3.00+, what a biotech small cap beauty!

$AKBA I keep buying 10 and 20 shares lol I have like 50 usd of buy power left 💪

YouTube link in my profile bio. Arc community is a helpful and friendly community filled with triple digit track record traders &amp; educational content, free community room (link in bio)

This is quite good. https://www.chartmill.com/stock/quote/AKBA/fundamental-analysis?key=a33c7a6e-2162-4da3-a2d6-37296dc486fb&amp;utm_source=stocktwits&amp;utm_medium=FA&amp;utm_content=AKBA&amp;utm_campaign=social_tracking

Vadadustat DD met efficacy &amp; safety endpoints.

Also, don’t forget Vadadustat DD met efficacy &amp; safety endpoints.

&amp; if that takes LITTLE BIT more time … very, very well spent.

concerning Vadadustat will be best outcome for us (Akebia, AKBA) &amp; product (Vadadustat) &amp; he is very pleased,

The Q&amp;A employs terms such as “multiple commercial parties, deal, best outcome for us &amp; product, little bit of time, very pleased.” The Q&amp;A also uses “it’s” or “it” four times and “process” five times.

Call, Butler answered Robert Hatlett’s (industry analyst) question by using following terms &amp; words: multiple commercial parties, best outcome for us/product, little bit of time, very pleased.

CHMP positive opinion is very value creating for us &amp; having an authorization creates more value … ultimately as you get to deal.

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Mar, 6, 2023

Dec, 1, 2022

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Jan, 9, 2023

Oct, 19, 2022

AKBA

Akebia Therapeutics Inc.

-38.05%

$1.13 - $0.70

Jan, 9, 2023

Nov, 29, 2022

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Mar, 6, 2023

Dec, 1, 2022

Nov, 10, 2022

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Jan, 9, 2023

Oct, 19, 2022

Oct, 11, 2022

AKBA

Akebia Therapeutics Inc.

-38.05%

$1.13 - $0.70

Jan, 9, 2023

Nov, 29, 2022

Oct, 22, 2022